Global Head of Pharmacovigilance and Safety Science jobs in United States
cer-icon
Apply on Employer Site
company-logo

Tubulis GmbH · 1 day ago

Global Head of Pharmacovigilance and Safety Science

Tubulis, Inc. is a clinical stage biotech company that generates uniquely matched antibody-drug conjugates (ADCs) with superior biophysical properties. The Global Head of Pharmacovigilance and Safety Science is responsible for medical, strategic, and operational oversight of drug safety, guiding safety strategy, ensuring compliance, and driving successful trial conduct for Tubulis assets across all stages of development.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Hiring Manager
Jennifer Metivier, MS
linkedin

Responsibilities

Develop and execute the overall drug safety and pharmacovigilance (PV) strategy aligned with company and global regulatory requirements, especially for oncology assets
Oversee safety surveillance, signal detection, risk assessment, and risk mitigation for investigational and marketed oncology products
Select and provide governance for external safety service providers (CROs) to ensure high-quality case handling and reporting
Ensure compliance with international PV regulations (FDA, EMA, ICH), SOPs, and best industry practices
Lead and build high-performing PV teams, including medical safety experts and regulatory specialists, fostering a collaborative and high-performance culture
Provide medical oversight of safety data, including the review of case safety reports (SAEs, SUSARs) and aggregate analyses
Lead the identification, evaluation, and management of safety signals using advanced analytics and real-world evidence (RWE)
Establish and maintain risk management plans, safety monitoring plans, data exchange agreements, and readiness for health authority inspections
Represent the company in safety-related interactions with regulatory agencies, partners, external stakeholders and independent Data Safety Monitoring Committees (DSMCs)
Collaborate cross-functionally with clinical development, clinical operations, data science, regulatory, medical affairs, and other teams integrating safety and optimize benefit-risk profiles across the product lifecycle

Qualification

Drug safetyPharmacovigilanceOncology experienceLeadershipAntibody Drug ConjugatesGlobal PV regulationsRisk management plansSafety databasesFluency in EnglishCommunication skillsStrategic decision-making

Required

Medical Doctor (MD, MBBS, DO) or equivalent clinical degree
12–15+ years in drug safety/pharmacovigilance with at least 5 years at a senior leadership level in biotech and pharma
Oncology experience is required
In-depth knowledge of global PV regulations and experience with safety and efficacy submissions (IND, BLA, NDA, MAA)
Experience with risk management plans, signal detection, aggregate safety data review, and case management
History of building, leading, and mentoring multidisciplinary teams
Familiarity with major safety databases (e.g. Argus), coding dictionaries (MedDRA), and digital safety systems
Outstanding communication skills and proven ability to influence, collaborate, and present safety strategy to senior leaders and regulatory authorities
Strategic decision-making abilities and the capacity to oversee budgets, resources, and department objectives in a dynamic environment
Fluency in English

Preferred

Experience with Antibody Drug Conjugates (ADCs) is a strong plus

Benefits

Impact that matters : Contribute to breakthrough therapies.
Global mindset : Work in an international, diverse team.
Grow & thrive : Develop your career in a supportive, fast-moving environment.
Innovation every day : Push boundaries with cutting-edge science.

Company

Tubulis GmbH

twittertwittertwitter
company-logo
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.

Funding

Current Stage
Growth Stage
Total Funding
$616.89M
Key Investors
Venrock Healthcare Capital PartnersAndera Partners
2025-10-15Series C· $400.62M
2024-03-14Series B· $139.3M
2022-05-03Series B· $63.15M

Leadership Team

leader-logo
Dominik Schumacher
CEO, Member of the Advisory Board
linkedin
leader-logo
Björn Hock
Chief Development Officer
linkedin
Company data provided by crunchbase